List of companies in Omega Funds's investment portfolio
Name | Description | Industry | Official Website | Location | ||
|---|---|---|---|---|---|---|
It is a biotech company that specializes in the development of drugs for the treatment of hypertension and other cardiovascular diseases. | ||||||
Senti Biosciences is a synthetic biology company. | ||||||
A company developing antibody-based biological medicines for kidney diseases and other chronic diseases. Visterra was acquired by Otsuka Pharmaceutical in 2018. | ||||||
Egalet Corporation is a pharmaceutical company that focuses on abuse resistance opioids | ||||||
Gossamer Bio is a clinical-stage biopharmaceutical public company developing products and therapies in the areas of immunology, inflammation, fibrosis and oncology. | ||||||
A synthetic biology company using CRISPR to develop a portfolio of genetic medicines. | ||||||
Editas Medicine is a genome editing company founded in 2013 that is using CRISPR technology to treat patients with genetically defined diseases. | ||||||
Formerly BioMedicines, Intarcia Therapeutics is an American biopharmaceutical company developing therapies for diseases with long-term treatment requirements. | ||||||
Kronos Bio is a Cambridge, Massachusetts-based therapeutics company working on research and development of therapies that modulate historically recalcitrant cancer targets. | ||||||
Translate Bio is a clinical-stage mRNA therapeutics company developing medicines to treat diseases caused by protein or gene dysfunction and vaccines against infectious disease pathogens. | ||||||
Adagio Therapeutics is a Waltham, Massachusetts-based biotechnology company involved in the research and development of therapeutic pharmaceuticals. | ||||||
Arcutis Biotherapeutics is a clinical-stage biopharmaceutical company in California that focuses developing and commercializing treatments for immune-mediated dermatological diseases and conditions, or immuno-dermatology. | ||||||
FoRx Therapeutics is a Basel-based biotechnology company developing a drug discovery platform for cancer drugs. | ||||||
A company focused on mapping and controlling the genes to treat diseases | ||||||
Small Molecules | ||||||
Anjarium is an early-stage biotechnology company developing next-generation, non-viral gene therapy therapeutics. | ||||||
A biotechnology company in Washington that focuses on developing safe and effective vaccines against infectious diseases. | ||||||
Arrakis is developing RNA-targeted small molecule (rSM) therapies to millions of patients. | ||||||
Artios Pharma develops cancer treatments that target DNA damage response (DDR) pathways to kill cancer cells selectively | ||||||
Amunix is an immuno-oncology company focused on developing immune-activating biotherapeutics for patients with solid tumor cancers. | ||||||
Imago BiosSciences is a clinical-stage therapeutics company developing treatments for malignant and life-threatening diseases for bone marrow. | ||||||
Dicerna Pharmaceuticals is a company that focuses on the discovery and development of treatments for inherited diseases. | ||||||
Prevail Therapeutics is a New York City-based biotechnology company and a wholly owned subsidiary of Eli Lilly and Company. | ||||||
Kezar Life Sciences is a therapies for autoimmune disorders founded in 2015 by John Fowler. | ||||||
Replimune Group, Inc. is a clinical-stage biotechnology company. |
